Skip to main content

Advertisement

Table 1 Calculated parameters for the ability of the GEPR to predict disease control

From: A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

Parameter KRAS-wildtype All patients KRAS-mutant
Specificity 0.32 0.4 0.5
Sensitivity 0.85 0.8 1
PPV 0.57 0.43 0.18
NPV 0.66 0.77 1
  1. NPV: negative predictive value; PPV positive predictive value